A third AML subset associated with increased HOX A/B expression is represented by the partial tandem duplication (PTD) of the KMT2A gene, occurring in 3–11% of adult de novo AML and associated with adverse outcomes. Here, KMT2A is linked to acute myeloid leukemia.